PBRM1 and colorectal cancer: We used immunohistochemical staining to examine 25 colorectal cancer samples treated with PD-1 immunotherapy and found a strong association between the lack of protein expression and LOF of PBRM1 with immunotherapy sensitivity (Figure 1D).